Bradley Louis Radoff is Director at HARTE HANKS INC (HHS). They have made 34 open-market trades across 11 companies since 0024, most recently 2026-06-15.
CIK 0001380585
26 open-market purchases totalling $5.8M since 0024, against 8 sales. Across 24 scored buys the stock is up 1.4% at ninety days, and 1.0 points behind the S&P over the same stretch.
24 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 54% | 54% | 42% |
| Avg Move | -0.3% | +3.5% | +1.4% |
| Alpha | -0.5% | +1.6% | -1.0% |
| Scored | 24 | 24 | 24 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RHEP | SELL | 2026-06-05 | 2026-08-04 | $1.15 | $6K | N/A | N/A | N/A |
| KVHI | SELL | 2026-05-27 | 2026-05-29 | $11.20 | $392K | -17.3% | +3.6% | -16.8% |
| RHEP | BUY | 2026-04-13 | 2026-08-04 | $1.33 | $19K | N/A | N/A | N/A |
| KVHI | BUY | 2026-02-12 | 2026-02-12 | $6.26 | $188K | -3.8% | +24.4% | +75.0% |
| HHS | BUY | 2024-12-05 | 2024-12-06 | $5.83 | $100K | -9.1% | -10.3% | -13.3% |
| HHS | BUY | 2024-12-04 | 2024-12-05 | $5.65 | $299K | -5.8% | -9.7% | -13.1% |
| HHS | BUY | 2024-08-13 | 2024-08-15 | $7.21 | $894K | +2.0% | +4.1% | -8.3% |
| HHS | BUY | 2023-12-01 | 2023-12-05 | $7.23 | $145K | -3.6% | -5.6% | +4.4% |
| HHS | BUY | 2023-11-29 | 2023-11-29 | $6.82 | $68K | -1.1% | -2.7% | +10.7% |
| FARM | BUY | 2023-09-15 | 2023-09-18 | $2.58 | $206K | -5.4% | +5.0% | +15.0% |
| FARM | BUY | 2022-10-05 | 2022-10-07 | $5.05 | $253K | +5.2% | +14.0% | -6.1% |
| HHS | SELL | 2022-08-15 | 2022-08-17 | $15.19 | $13.6M | -5.3% | -26.2% | -32.0% |
| ENZ | BUY | 2022-07-12 | 2022-07-13 | $2.27 | $28K | +2.3% | +11.9% | -11.9% |
| ENZ | BUY | 2022-07-05 | 2022-07-06 | $2.20 | $264K | +15.6% | +12.9% | +3.6% |
| ENZ | BUY | 2022-06-15 | 2022-06-16 | $2.20 | $276K | -13.8% | +11.6% | -5.2% |
| EGY | SELL | 2021-11-15 | 2021-11-17 | $3.79 | $1.1M | -18.0% | -19.8% | +47.5% |
| EGY | SELL | 2021-11-08 | 2021-11-10 | $4.00 | $7.2M | -10.0% | -18.4% | +35.7% |
| RMCF | BUY | 2021-10-27 | 2021-10-29 | $8.71 | $43K | +2.8% | -0.4% | -13.4% |
| RMCF | BUY | 2021-10-21 | 2021-10-25 | $8.50 | $115K | +1.1% | +2.2% | -11.9% |
| RMCF | BUY | 2021-10-15 | 2021-10-19 | $8.20 | $16K | +4.6% | +12.5% | -7.6% |
| RMCF | BUY | 2021-10-07 | 2021-10-12 | $7.58 | $93K | +5.3% | +7.5% | -7.4% |
| RMCF | BUY | 2021-10-04 | 2021-10-06 | $7.28 | $192K | +4.9% | +15.7% | +0.9% |
| RMCF | BUY | 2021-09-24 | 2021-09-28 | $7.42 | $47K | +1.6% | +13.6% | +8.7% |
| RMCF | BUY | 2021-09-07 | 2021-09-09 | $8.25 | $1.1M | -7.2% | -10.0% | -1.7% |
| HRTH | BUY | 2021-09-02 | 2021-09-03 | $6.88 | $28K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| RMCF |
| 490,979 |
| $443K |
| HHS | 27,861 | $121K |
| RHEP | 171,263 | — |
| PPP | 2,000 | — |
| HRTH | 677,678 | — |
| Total | $37.9M |
Shares reported on the most recent Form 4, priced at the 2026-08-04 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.